Cost Per Responder Analysis of Guselkumab versus Adalimumab using Efficacy Results fromm a Head-to-Head Clinical Trial in Patients with Moderate to Severe Plaque Psoriasis
A Teeple, E Muser
Abstract Not Available
psoriasis; adalimumab; guselkumab; biologic therapy; cost analysis; clinical trial
Abstract - 173 Poster PDF - 114
- There are currently no refbacks.